7-Dec-2025 New tool reveals hidden metabolic weakness in blood cancers: Duke-NUS study Duke-NUS Medical School Peer-Reviewed Publication
7-Dec-2025 Lower doses of immunotherapy for skin cancer give better results Karolinska Institutet Peer-Reviewed Publication
7-Dec-2025 ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment University of Miami Miller School of Medicine Reports and Proceedings
7-Dec-2025 ASH 2025: Researchers identify CD40 as potential biomarker for a type of nodal T cell lymphoma University of Texas M. D. Anderson Cancer Center Meeting Announcement
7-Dec-2025 ASH 2025: Shorter azacitidine regimen safely improves outcomes in lower-risk MDS patients University of Texas M. D. Anderson Cancer Center Reports and Proceedings
7-Dec-2025 ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma University of Texas M. D. Anderson Cancer Center Reports and Proceedings
7-Dec-2025 Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes American Society of Hematology Reports and Proceedings
7-Dec-2025 New findings support a chemo-free approach for treating Ph+ ALL American Society of Hematology Reports and Proceedings
7-Dec-2025 Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL American Society of Hematology Reports and Proceedings
6-Dec-2025 University of Cincinnati experts present research at annual hematology event University of Cincinnati Meeting Announcement